杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/05/02 | 2,091 | 2,144 | 2,091 | 2,144 | -40 | -1.8% | 183,100 |
2016/04/28 | 2,259 | 2,275 | 2,182 | 2,184 | -78 | -3.4% | 283,000 |
2016/04/27 | 2,316 | 2,325 | 2,249 | 2,262 | -52 | -2.2% | 229,900 |
2016/04/26 | 2,296 | 2,329 | 2,287 | 2,314 | -2 | -0.1% | 127,800 |
2016/04/25 | 2,359 | 2,359 | 2,302 | 2,316 | -42 | -1.8% | 247,900 |
2016/04/22 | 2,326 | 2,361 | 2,312 | 2,358 | +19 | +0.8% | 158,900 |
2016/04/21 | 2,332 | 2,349 | 2,312 | 2,339 | +42 | +1.8% | 133,200 |
2016/04/20 | 2,305 | 2,344 | 2,285 | 2,297 | +4 | +0.2% | 167,600 |
2016/04/19 | 2,296 | 2,346 | 2,268 | 2,293 | +54 | +2.4% | 196,300 |
2016/04/18 | 2,222 | 2,261 | 2,222 | 2,239 | -54 | -2.4% | 108,800 |
2016/04/15 | 2,294 | 2,320 | 2,286 | 2,293 | -15 | -0.6% | 143,800 |
2016/04/14 | 2,257 | 2,312 | 2,239 | 2,308 | +80 | +3.6% | 251,900 |
2016/04/13 | 2,179 | 2,236 | 2,175 | 2,228 | +86 | +4% | 295,200 |
2016/04/12 | 2,138 | 2,184 | 2,138 | 2,142 | -18 | -0.8% | 184,400 |
2016/04/11 | 2,147 | 2,171 | 2,124 | 2,160 | ±0 | ±0% | 187,900 |
2016/04/08 | 2,083 | 2,179 | 2,071 | 2,160 | +61 | +2.9% | 253,000 |
2016/04/07 | 2,042 | 2,110 | 2,037 | 2,099 | +64 | +3.1% | 206,600 |
2016/04/06 | 2,038 | 2,057 | 2,018 | 2,035 | +2 | +0.1% | 206,400 |
2016/04/05 | 2,096 | 2,130 | 2,029 | 2,033 | -26 | -1.3% | 213,600 |
2016/04/04 | 2,076 | 2,103 | 2,044 | 2,059 | +11 | +0.5% | 217,700 |
2016/04/01 | 2,141 | 2,141 | 2,041 | 2,048 | -96 | -4.5% | 187,900 |
2016/03/31 | 2,210 | 2,217 | 2,141 | 2,144 | -69 | -3.1% | 235,700 |
2016/03/30 | 2,228 | 2,233 | 2,201 | 2,213 | +2 | +0.1% | 202,700 |
2016/03/29 | 2,198 | 2,227 | 2,193 | 2,211 | -21 | -0.9% | 157,400 |
2016/03/28 | 2,198 | 2,237 | 2,170 | 2,232 | +66 | +3% | 186,600 |
2016/03/25 | 2,194 | 2,200 | 2,158 | 2,166 | -17 | -0.8% | 134,300 |
2016/03/24 | 2,195 | 2,209 | 2,170 | 2,183 | -15 | -0.7% | 274,300 |
2016/03/23 | 2,190 | 2,240 | 2,188 | 2,198 | +39 | +1.8% | 290,100 |
2016/03/22 | 2,119 | 2,178 | 2,107 | 2,159 | +73 | +3.5% | 211,800 |
2016/03/18 | 2,106 | 2,128 | 2,065 | 2,086 | -36 | -1.7% | 273,400 |
2016/03/17 | 2,167 | 2,171 | 2,108 | 2,122 | -30 | -1.4% | 288,300 |
2016/03/16 | 2,162 | 2,191 | 2,151 | 2,152 | -38 | -1.7% | 182,200 |
2016/03/15 | 2,183 | 2,208 | 2,173 | 2,190 | +8 | +0.4% | 265,000 |
2016/03/14 | 2,183 | 2,222 | 2,170 | 2,182 | +21 | +1% | 199,500 |
2016/03/11 | 2,138 | 2,174 | 2,117 | 2,161 | +6 | +0.3% | 249,000 |
2016/03/10 | 2,129 | 2,164 | 2,127 | 2,155 | +51 | +2.4% | 236,500 |
2016/03/09 | 2,115 | 2,128 | 2,078 | 2,104 | -45 | -2.1% | 269,500 |
2016/03/08 | 2,202 | 2,204 | 2,131 | 2,149 | -83 | -3.7% | 221,100 |
2016/03/07 | 2,253 | 2,264 | 2,224 | 2,232 | -19 | -0.8% | 151,100 |
2016/03/04 | 2,232 | 2,257 | 2,217 | 2,251 | +13 | +0.6% | 215,900 |
2016/03/03 | 2,220 | 2,253 | 2,214 | 2,238 | +7 | +0.3% | 144,500 |
2016/03/02 | 2,207 | 2,242 | 2,195 | 2,231 | +69 | +3.2% | 219,600 |
2016/03/01 | 2,128 | 2,171 | 2,118 | 2,162 | +20 | +0.9% | 234,400 |
2016/02/29 | 2,162 | 2,190 | 2,142 | 2,142 | -7 | -0.3% | 236,300 |
2016/02/26 | 2,126 | 2,167 | 2,121 | 2,149 | +21 | +1% | 194,500 |
2016/02/25 | 2,100 | 2,139 | 2,100 | 2,128 | +41 | +2% | 164,200 |
2016/02/24 | 2,085 | 2,135 | 2,064 | 2,087 | -4 | -0.2% | 261,500 |
2016/02/23 | 2,116 | 2,116 | 2,075 | 2,091 | -36 | -1.7% | 234,600 |
2016/02/22 | 2,092 | 2,144 | 2,092 | 2,127 | +3 | +0.1% | 237,900 |
2016/02/19 | 2,111 | 2,137 | 2,083 | 2,124 | -16 | -0.7% | 213,900 |
2251~
2300
件表示中 / 3743件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | -2.4% | -52.3% | 3.80% | 17.94倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 207,800円 | +3.1% | -6.5% | 2.31% | 9.64倍 | 1.02倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 298,500円 | +5.1% | -7.0% | 2.68% | 19.59倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
JCRファーマ | 67,300円 | +14.3% | - | 2.97% | 27.33倍 | 1.75倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 210,100円 | +4.1% | -3.1% | 2.76% | 18.19倍 | 1.59倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム